Summary
Single-chain tetanus toxin (toxin S) was prepared from short-term cultures by lysis under protection with protease inhibitors, precipitation with 40% ammonium sulfate, gel filtration, and chromatography on DEAE ion exchanger. Its limited proteolysis by trypsin, post-arginine cleaving enzyme from mouse submaxillary gland and clostripain led to bichainal derivatives (BT, BA, BCl) consisting of a heavy chain and a larger version of the light chain. The latter was then converted by trypsin into a small version which comigrated with the light chain of bichainal extracellular toxin (BE). The light chain produced by chymotrypsin (BC) and elastase (BEI) was of intermediate size. The nick region serves as substrate for all esteroproteases investigated and comprises between one and two kDa. Limited proteolysis increased the hydrophilicity (BT > BE > S) in hydrophobic interaction HPLC, and anionic behaviour (BC > BE > BT > S) in DEAE ion exchanger HPLC.
The bichainal toxins assessed (BC, BE or BT) were about two times more toxic than toxin S (LD50, mouse s. c. 2 ng/kg vs. 4 ng/kg). They were five to twelve times more potent than toxin S in three in vitro assays measuring the prevention of neurotransmitter release, i. c. on the phrenic nerve-hemidiaphragm preparation of the mouse (acetylcholine, with toxin BE and BT), on primary brain cell cultures from the mouse ([3H]noradrenaline, with toxin BE and BT), and on brain homogenate from rats ([3H]noradrenaline, with toxin BA, BC, BE and BT).
Thus single-chain toxin is a less potent precursor of, or protoxin for, various bichainal isotoxins. The term tetanus toxin covers a family of agents that differ by their posttranslational processing.
Similar content being viewed by others
Abbreviations
- Toxin S:
-
single-chain tetanus toxin
- toxin B:
-
bichainal tetanus toxins, prepared by treatment of toxin S with trypsin (BT), chymotrypsin (BC), post-arginine cleaving enzyme (BA), clostripain (BCI), or elatase (BEI)
- toxin BE:
-
bichainal extracellular tetanus toxin
References
An der Lan B, Habig WH, Hardegree MC, Chrambach A (1980) Heterogeneity of 125I-labeled tetanus toxin in isoelectric focusing on polyacrylamide gel and polyacrylamide-gel electrophoresis. Arch Biochem Biophys 200:206–215
Bergey GK, Habig WH, Lin C (1986) Nicking of tetanus toxin increases activity. Ann Neurol 20:137–138
Bigalke H, Heller I, Bizzini B, Habermann E (1981) Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord. Naunyn-Schmiedeberg's Arch Pharmacol 316:244–251
Chiu W, Rankert D, Cumming RA, Robinson JP (1982) Characterization of crystalline filtrate tetanus toxin. J Ultrastruct Res 79:285–293
Critchley DR, Habig WH, Fishman PH (1986) Reevaluation of the role of gangliosides as receptors for tetanus toxin. J Neurochem 47:213–222
DiMari SJ, Hash JH, Robinson JP (1982) Characterization of tetanus toxins and toxin components by amino terminal analysis. Arch Biochem Biophys 214:354–365
Eisel U, Jarausch W, Goretzki K, Henschen A, Engels J, Weller U, Hudel M, Habermann E, Niemann H (1986) Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. EMBO J 5:2495–2502
Fairweather NF, Lyness VA (1986) The complete nucleotide sequence of tetanus toxin. Nuc Acid Res 14:7809–7812
Habermann E (1988) Inhibition by tetanus and botulinum A toxin of the release of [3H]noradrenaline and [3H]GABA from rat brain homogenate. Experientia 44:224–226
Habermann E, Albus U (1986) Interaction between tetanus toxin and rabbit kidney: A comparison with rat brain preparations. J Neurochem 46:1219–1226
Habermann E, Dreyer F (1986) Clostridial neurotoxins: Handling and action at the cellular and molecular level. Current Topics Microbiol Immunol 129:93–179
Habermann E, Tayot JL (1985) Interaction of solid-phase gangliosides with tetanus toxin and tetanus toxoid. Toxicon 23:913–920
Habermann E, Dreyer F, Bigalke H (1980) Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum A toxin. Naunyn-Schmiedeberg's Arch Pharmacol 311:33–40
Habermann E, Müller H, Hudel M (1988) Tetanus toxin, and botulinum A and C neurotoxins inhibit noradrenaline release from cultured mouse brain. J Neurochem 51 (in press)
Helting TB, Parschat S, Engelhardt H (1979) Structure of tetanus toxin. Demonstration and separation of a specific enzyme converting intracellular tetanus toxin to the extracellular form. J Biol Chem 254:10728–10733
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T 4. Nature 227: 680–685
Latham WC, Bent DF, Levine L (1962) Tetanus toxin production in the absence of protein. Appl Microbiol 10:146–152
Markwell MAK, Haas SM, Bieber LL, Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206–210
Matsuda M, Yoneda M (1974) Dissociation of tetanus neurotoxin into two polypeptide fragments. Biochem Biophys Res Comm 57:1257–1262
Montecucco C (1986) How does tetanus toxin bind to neuronal membranes? Trends Biochem Sci 11:314–317
Mueller JH, Miller PA (1954) Variable factors influencing the production of tetanus toxin. J Bacteriol 68:271–277
Neubauer V, Helting TB (1979) Structure of tetanus toxin. N-Terminal amino acid analysis of the two molecular forms of tetanus toxin and its composite chains. Biochem Biophys Res Commun 86:635–642
Ozutsumi K, Sugimoto N, Matsuda M (1985) Rapid, simplified method for production and purification of tetanus toxin. Appl Environmental Microbio1 49:939–943
Pierce EJ, Davison MD, Parton RG, Habig WH, Critchley DR (1986) Characterization of tetanus binding to rat brain membranes. Evidence for a high affinity proteinase-sensitive receptor. Biochem J 236:845–852
Robinson JP, Hash JH (1982) A review of the molecular structure of tetanus toxin. Mol Cell Biochem 48:33–44
Simpson LL (1981) The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 33:155–188
van Heyningen S (1976) Binding of ganglioside by the chains of tetanus toxin. FEBS Lett 68:5–7
Weller U, Taylor CF, Habermann E (1986) Quantitative comparison between tetanus toxin, some fragments and toxoid for binding and axonal transport in the rat. Toxicon 24:1055–1063
Weller U, Mauler F, Habermann E (1988) Monochainal tetanus toxin: Preparation, protoxin properties and proteolytic conversion into isotoxins. Zbl Bacteriol Mikrobiol Hyg I. Abt Suppl 17:121–122
Author information
Authors and Affiliations
Additional information
Send offprint requests to E. Habermann at the above address
Rights and permissions
About this article
Cite this article
Weller, U., Mauler, F. & Habermann, E. Tetanus toxin: Biochemical and pharmacological comparison between its protoxin and some isotoxins obtained by limited proteolysis. Naunyn-Schmiedeberg's Arch Pharmacol 338, 99–106 (1988). https://doi.org/10.1007/BF00174855
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00174855